Molecular Pathogenesis of Familial Wolff‐Parkinson‐White Syndrome.

DOI IR Web Site PubMed 1 Citations 101 References Open Access
  • Miyamoto Licht
    Laboratory of Pharmacology and Physiological Sciences, Frontier Laboratories for Pharmaceutical Sciences, Institute of Biomedical Sciences, University of Tokushima Graduate School, Tokushima, Japan Department of Medical Pharmacology, Institute of Biomedical Sciences

Bibliographic Information

Other Title
  • Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome. : Molecular Mechanisms of Cardiac Glycogen Regulation by AMPK
  • 〜Molecular Mechanisms of Cardiac Glycogen Regulation by AMPK〜

Search this article

Abstract

<p>Familial Wolff‐Parkinson‐White (WPW) syndrome is an autosomal dominant inherited disease and consists of a small percentage of WPW syndrome which exhibits ventricular pre‐excitation by development of accessory atrioventricular pathway. A series of mutations in PRKAG2 gene encoding gamma2 subunit of 5'AMP‐activated protein kinase (AMPK) has been identified as the cause of familial WPW syndrome. AMPK is one of the most important metabolic regulators of carbohydrates and lipids in many types of tissues including cardiac and skeletal muscles. Patients and animals with the mutation in PRKAG2 gene exhibit aberrant atrioventricular conduction associated with cardiac glycogen overload. Recent studies have revealed “novel" significance of canonical pathways leading to glycogen synthesis and provided us profound insights into molecular mechanism of the regulation of glycogen metabolism by AMPK. This review focuses on the molecular basis of the pathogenesis of cardiac abnormality due to PRKAG2 mutation and will provide current overviews of the mechanism of glycogen regulation by AMPK. J. Med. Invest. 65:1‐8, February, 2018</p>

Journal

Citations (1)*help

See more

References(101)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top